Search Results
Facet (Page)
Refine Your Search
Audiences
Content Formats
Events
Sections
Divisions
Programs
- Genome Technology Program5
- Impact of Genomic Variation on Function (IGVF) Consortium3
- NHGRI Genomic Data Science Analysis, Visualization and Informatics Lab-space (AnVIL)1
- Genomics Research to Elucidate the Genetics of Rare Diseases (GREGOR) Consortium2
- Developmental Genotype-Tissue Expression (dGTEx)1
- Ethical, Legal and Social Implications (ELSI) Research Program2
- Genomics-Enabled Learning Health Systems (gLHS)1
Educational Resources
Susceptibility is a condition of the body that increases the likelihood that the individual will develop a particular disease.
Research at NHGRI
The Medical Genetics Branch studies inherited disorders of metabolism and of human development.
… understand inherited disorders of metabolism and of human development. MGB investigators focus on human genetics, … involve the direct study of human subjects as well as the development and use of experimental model systems, such as … questions regarding disease pathophysiology and human development. In addition to making extensive and selective …
News Release
Researchers funded by NHGRI’s Genome Technology Program include a wide range of investigators with a variety of scientific expertise.
… . Over the past 20 years, the program has fueled the development of novel technologies for studying the human … the program has since expanded and now supports the development of additional genomic technologies. These … tool to understand complex biological processes such as development and cancer.  … While these snippets offer a …
The Genomics Landscape
In the March 2018 edition of The Genomics Landscape, NHGRI Director Eric Green highlights a strategic planning effort to establish a 2020 vision for genomics.
… examples of these areas include: genomic technology development; genomic variation and its functional … care; research and clinical training in genomics; policy development and implementation to enhance data sharing; and … funded by NHGRI. This resource was debuted at a policy development workshop held last September and hosted by the …
News
NHGRI launched a new round of strategic planning to establish a 2020 vision for genomics research that will accelerate scientific and medical breakthroughs.
… broadly applicable areas, such as genomic technology development; using genomic information in patient care; and …
News Release
Researchers developed a technique that will aid in a more accurate reconstruction of human genomes.
News Release
TCF1 (for T cell factor-1) is essential for the creation and persistence of disease-fighting antibodies in the bloodstream.
… Schwartzberg said. If the presence of TCF1 is vital to the development of TFH cells, then learning how to manipulate … "may help shed light on pathways important for the development of vaccines and immune therapies targeting viral … transcription factor, Pamela Schwartzberg, vaccine development, genetic disease … TCF1 (for T cell factor-1) is …
Administrative
NHGRI branch responsible for policy development and analysis related to advances in genomics research.
… of the Division of Genomics and Society conducts policy development and analysis that enables the National Human … Analysis Branch … NHGRI branch responsible for policy development and analysis related to advances in genomics research. … NHGRI branch responsible for policy development and analysis related to advances in genomics …
News Release
Researchers build a statistical model using family health history to improve disease risk assessment
Researchers at the National Human Genome Research Institute (NHGRI) have developed a new statistical model that can predict the risk for developing diseases by combining information about family member health and lifestyle factors from family members.
… to treat. T2D is known as a complex disease because its development depends strongly on a person’s genetic …
News Release
A team from the NIH has surmounted a major obstacle to testing potential drug therapies for a rare, genetic condition called Gaucher disease.
… are helping to better explain the disease and may lead to development of new drugs for patients with this condition. In …